Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenji Shimodaira
Mp49-16 Factors Predicting Failure to Follow Pre-Scheduled Gemcitabine Plus Cisplatin Chemotherapy Regimen for Urothelial Carcinoma
Journal of Urology
Urology
Related publications
Gemcitabine and Cisplatin Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Carcinoma: Predicting Response and Assessing Outcomes
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Efficacy of Fluoropyrimidine-Based Chemotherapy in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin: Retrospective Analysis of 321 Patients
British Journal of Cancer
Cancer Research
Oncology
Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder
Japanese Journal of Urology
Urology
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.
Research in Oncology
P3.17-22 Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prognostic Factors for Response to Cisplatin-Based Chemotherapy in Advanced Cervical Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
